Robert Bookstein
- Ophthalmology top 0.2%
- Ocular Oncology and Treatments 20
- Oncology top 0.5%
- Cancer-related Molecular Pathways 24
- Cancer Research top 1%
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 8
- PI3K/AKT/mTOR signaling in cancer 7
- Genetics top 1%
- Virus-based gene therapy research 9
-
- Prostate Cancer Treatment and Research 7
-
- Genetic factors in colorectal cancer 6
-
- interferon and immune responses 5
- Co-authors
- Wen‐Hwa LeeJin‐Yuh ShewEva Y.-H.P. LeePhang‐Lang ChenFrank HongDonal MacGroganPeter ScullyYumay Chen
- Cited by
- OphthalmologyOncologyCancer Research
- Journals
- Science (5 papers)Proceedings of the National Academy of Sciences (4 papers)Oncogene (3 papers)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Robert Bookstein
52 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Ophthalmology 1.7k
- Oncology 3.8k
- Cancer Research 1.3k
- Molecular Biology 4.3k
- Genetics 1.7k
Countries citing papers authored by Robert Bookstein
This map shows the geographic impact of Robert Bookstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bookstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bookstein more than expected).
Fields of papers citing papers by Robert Bookstein
This network shows the impact of papers produced by Robert Bookstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bookstein. The network helps show where Robert Bookstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Bookstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 36 | |
| 2 | 2000 | 156 | |
| 3 | 1999 | 29 | |
| 4 | 1999 | 29 | |
| 5 | 1997 | 42 | |
| 6 | 1997 | 54 | |
| 7 | 1997 | 9 | |
| 8 | 1997 | 109 | |
| 9 | p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer. | 1996 | 35 |
| 10 | 1996 | 93 | |
| 11 | 1994 | 151 | |
| 12 | 1994 | 160 | |
| 13 | 1994 | 20 | |
| 14 | 1993 | 19 | |
| 15 | 1991 | 16 | |
| 16 | 1990 | 3 | |
| 17 | 1990 | 61 | |
| 18 | 1988 | 24 | |
| 19 | 1988 | 32 | |
| 20 | The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activitybreakdown → | 1987 | 535 |
About Robert Bookstein
Robert Bookstein is a scholar working on Ophthalmology, Oncology and Cancer Research, having authored 52 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (24 papers), Ocular Oncology and Treatments (20 papers), Virus-based gene therapy research (9 papers), Ubiquitin and proteasome pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Prostate Cancer Treatment and Research (7 papers), Genetic factors in colorectal cancer (6 papers) and interferon and immune responses (5 papers). The work is most often cited by research in Ophthalmology (1.7k citations), Oncology (3.8k citations) and Cancer Research (1.3k citations). Robert Bookstein has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Wen‐Hwa Lee, Jin‐Yuh Shew, Eva Y.-H.P. Lee, Phang‐Lang Chen, Frank Hong, Donal MacGrogan, Peter Scully, Yumay Chen, Theodore Friedmann and David G. Bostwick. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences, Oncogene, Genomics and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.